Broadline Capital
Broadline Capital, established in 2005 and headquartered in New York, is a private equity firm specializing in growth capital and impact investments, primarily in North America and Asia. The firm targets industries such as economic empowerment, sustainable energy, health, technology, and retail products, focusing on category leaders and innovators who are transforming their respective markets. Broadline Capital aims to leverage its extensive network and domain expertise to identify high-potential investment opportunities characterized by strong growth and profitability. Beyond providing financial support, the firm actively works with portfolio companies to enhance revenue growth, improve operations, and streamline processes. With a team composed of experienced entrepreneurs and former CEOs, Broadline Capital emphasizes building trust-based relationships and provides strategic guidance to help businesses realize their full potential. This approach ensures that the firm not only invests in promising companies but also contributes significantly to their development and success.
8 past transactions
EndoSphere
Series C in 2016
Endosphere is a medical device company based in Columbus, Ohio, founded in 2006. It specializes in developing innovative non-invasive endoscopic therapies aimed at addressing gastrointestinal disorders and metabolic diseases, including obesity, non-alcoholic fatty liver disease, and type 2 diabetes. The company’s unique devices leverage the body’s natural physiology to facilitate safe and effective weight loss, eliminating the necessity for surgical interventions or medications. By focusing on non-invasive solutions, Endosphere aims to improve patient outcomes and enhance the treatment landscape for those suffering from these conditions.
Powermers
Series B in 2016
Powermers Inc. is a company based in Westerville, Ohio, that specializes in the design and production of electro-conductive polymers aimed at enhancing the performance of energy storage devices, such as lithium-ion and lithium-air batteries, as well as super-capacitors. Founded in 2012, Powermers focuses on developing transition-metal based electro-conductive polymers, which serve as efficient catalysts and electrochemical coating solutions for battery electrodes. The company also manufactures electro-conductive nanopolymer electrodes that self-assemble within carbon-based electrodes, thereby boosting their storage capacity. As an innovator in advanced materials, Powermers holds patents for its nano-scale catalytic polymers, coatings, and binders, which have various applications in energy storage technology.
China Rapid Finance
Series C in 2015
China Rapid Finance is an online consumer lending marketplace that focuses on providing access to credit for China's emerging middle class. Founded in 2001 by Dr. Zane Wang, the company aims to tap into the vast potential of the consumer credit market, which is projected to exceed RMB 5.4 trillion (approximately US $870 billion) by 2020. The company leverages advanced technology, including a proprietary Big Data analytics platform and an automated credit decisioning system, to offer socially inclusive financing to around 500 million economically active individuals who have traditionally lacked access to bank credit. With a strong emphasis on credit risk management and transparency, China Rapid Finance operates with over 5,000 employees and maintains 80 data verification centers throughout the country. Dr. Wang, a noted expert in consumer credit innovation, has played a pivotal role in shaping the company's direction and the broader lending marketplace in China.
EndoSphere
Series B in 2012
Endosphere is a medical device company based in Columbus, Ohio, founded in 2006. It specializes in developing innovative non-invasive endoscopic therapies aimed at addressing gastrointestinal disorders and metabolic diseases, including obesity, non-alcoholic fatty liver disease, and type 2 diabetes. The company’s unique devices leverage the body’s natural physiology to facilitate safe and effective weight loss, eliminating the necessity for surgical interventions or medications. By focusing on non-invasive solutions, Endosphere aims to improve patient outcomes and enhance the treatment landscape for those suffering from these conditions.
EndoSphere
Series A in 2011
Endosphere is a medical device company based in Columbus, Ohio, founded in 2006. It specializes in developing innovative non-invasive endoscopic therapies aimed at addressing gastrointestinal disorders and metabolic diseases, including obesity, non-alcoholic fatty liver disease, and type 2 diabetes. The company’s unique devices leverage the body’s natural physiology to facilitate safe and effective weight loss, eliminating the necessity for surgical interventions or medications. By focusing on non-invasive solutions, Endosphere aims to improve patient outcomes and enhance the treatment landscape for those suffering from these conditions.
Powermers
Series A in 2011
Powermers Inc. is a company based in Westerville, Ohio, that specializes in the design and production of electro-conductive polymers aimed at enhancing the performance of energy storage devices, such as lithium-ion and lithium-air batteries, as well as super-capacitors. Founded in 2012, Powermers focuses on developing transition-metal based electro-conductive polymers, which serve as efficient catalysts and electrochemical coating solutions for battery electrodes. The company also manufactures electro-conductive nanopolymer electrodes that self-assemble within carbon-based electrodes, thereby boosting their storage capacity. As an innovator in advanced materials, Powermers holds patents for its nano-scale catalytic polymers, coatings, and binders, which have various applications in energy storage technology.
China Rapid Finance
Series B in 2007
China Rapid Finance is an online consumer lending marketplace that focuses on providing access to credit for China's emerging middle class. Founded in 2001 by Dr. Zane Wang, the company aims to tap into the vast potential of the consumer credit market, which is projected to exceed RMB 5.4 trillion (approximately US $870 billion) by 2020. The company leverages advanced technology, including a proprietary Big Data analytics platform and an automated credit decisioning system, to offer socially inclusive financing to around 500 million economically active individuals who have traditionally lacked access to bank credit. With a strong emphasis on credit risk management and transparency, China Rapid Finance operates with over 5,000 employees and maintains 80 data verification centers throughout the country. Dr. Wang, a noted expert in consumer credit innovation, has played a pivotal role in shaping the company's direction and the broader lending marketplace in China.
China Rapid Finance
Series A in 2005
China Rapid Finance is an online consumer lending marketplace that focuses on providing access to credit for China's emerging middle class. Founded in 2001 by Dr. Zane Wang, the company aims to tap into the vast potential of the consumer credit market, which is projected to exceed RMB 5.4 trillion (approximately US $870 billion) by 2020. The company leverages advanced technology, including a proprietary Big Data analytics platform and an automated credit decisioning system, to offer socially inclusive financing to around 500 million economically active individuals who have traditionally lacked access to bank credit. With a strong emphasis on credit risk management and transparency, China Rapid Finance operates with over 5,000 employees and maintains 80 data verification centers throughout the country. Dr. Wang, a noted expert in consumer credit innovation, has played a pivotal role in shaping the company's direction and the broader lending marketplace in China.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.